EMILIO JOSE
GONZALEZ PARRA
PROFESORA SUSTITUTA/PROFESOR SUSTITUTO
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (9)
2022
-
Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study
Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1856-1864
2021
-
Control of phosphorus and prevention of fractures in the kidney patient
Nefrologia, Vol. 41, Núm. 1, pp. 7-14
-
Hemodialysis Centers Guide 2020
Nefrologia, Vol. 41, pp. 1-77
2019
2015
-
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
Health Economics Review, Vol. 5, Núm. 1
-
Cost-effectiveness analysis of lanthanum carbonate versus sevelamer hydrochloride in the treatment of hyperphosphatemia in patients with end-stage renal disease in Spain
Pharmacoeconomics - Spanish Research Articles, Vol. 12, Núm. 1, pp. 11-22
2014
-
Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection
Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056
2013
-
Bisphenol a in chronic kidney disease
International Journal of Nephrology, Vol. 2013
2012
-
Estudio Español sobre anticoagulación en hemodiálisis
Nefrologia, Vol. 32, Núm. 2, pp. 143-152